India sets aside Rs 50,000 cr to vaccinate population against Covid: Report

The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose

Coronavirus, vaccine, covid
Starting this weekend, Indians will be celebrating several festivals that could lead to a sharp jump in daily virus infections.
Siddhartha Singh & Chris Kay | Bloomberg
3 min read Last Updated : Oct 23 2020 | 12:42 AM IST
India’s government has set aside about Rs 50,000 crore ($7 billion) to vaccinate the world’s most populous country after China against the coronavirus, according to people with knowledge of the matter.

Prime Minister Narendra Modi’s administration estimates an all-in cost of about $6-$7 (Rs 440-Rs 520) per person in the nation of 1.3 billion, the people said, asking not to be identified as the details are private. The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose, they added.

A finance ministry spokesman couldn’t immediately be reached when tried on his mobile.

“I doubt that the marginal cost of a vaccine would be anything close to that number at the volumes that India will purchase. There’s one large buyer — India — and one large seller, potentially,” said Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy, which has offices in Washington and New Delhi. “A lot will come down to negotiations and the government has a lot more power in these situations.”

Adar Poonawalla, head of the Serum Institute of India, the world’s largest manufacturer of vaccines, has predicted the nation would need about Rs 800 billion to procure and inoculate people living everywhere from the Himalayas to the remote Andaman & Nicobar islands. Apart from buying the treatment, transporting them from manufacturing sites would be a massive undertaking.


Delivering a vaccine across India “will be a gigantic task”, Mahesh Devnani, an associate professor at the Post Graduate Institute of Medical Education and Research in Chandigarh, said Wednesday on a webinar. “We need a prioritisation plan, everyone cannot have it initially.”

By one estimate, airlifting single-dose regimens to protect the world’s population would require space in about 8,000 cargo planes.

The biggest challenge for India will be building up cold-chain logistics to distribute vaccines across India in a short period of time, Kiran Mazumdar-Shaw, the founder and chairman of Biocon, said at the Bloomberg India Economic Forum last week.

“I do hope by the end of November that we are able to say we have a plan” and digital platforms to help roll out vaccines, she said.

While a government-backed panel predicts that India is past the peak of infections and may contain the spread by February, the nation has taken a massive blow to economic growth and Modi has been reopening the economy. Starting this weekend, Indians will be celebrating several festivals that could lead to a sharp jump in daily virus infections.

Modi on Tuesday said his government will ensure all Indians have access to a Covid-19 vaccine as soon it is ready.


Vaccine Math:

  • India is said to estimate two injections per person at $2 a shot
  • Another $2-$3 is said to be set aside per individual as infrastructure costs such as storage and transport
  • Details based on recommendations of a working group, the people said

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IndiaCoronavirus VaccineNarendra ModiCentreFinance MinistryIndian Economy

Next Story